Pharma-Bio Serv (PBSV) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $10.9 million.
- Pharma-Bio Serv's Cash & Current Investments fell 1483.56% to $10.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $10.9 million, marking a year-over-year decrease of 1483.56%. This contributed to the annual value of $10.9 million for FY2025, which is 1483.56% down from last year.
- According to the latest figures from Q4 2025, Pharma-Bio Serv's Cash & Current Investments is $10.9 million, which was down 1483.56% from $10.7 million recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's Cash & Current Investments registered a high of $19.0 million during Q1 2021, and its lowest value of $10.4 million during Q2 2025.
- For the 5-year period, Pharma-Bio Serv's Cash & Current Investments averaged around $14.2 million, with its median value being $14.4 million (2022).
- Per our database at Business Quant, Pharma-Bio Serv's Cash & Current Investments soared by 2447.49% in 2021 and then crashed by 2274.59% in 2025.
- Over the past 5 years, Pharma-Bio Serv's Cash & Current Investments (Quarter) stood at $17.5 million in 2021, then fell by 17.21% to $14.5 million in 2022, then grew by 3.56% to $15.0 million in 2023, then decreased by 14.9% to $12.7 million in 2024, then dropped by 14.84% to $10.9 million in 2025.
- Its Cash & Current Investments stands at $10.9 million for Q4 2025, versus $10.7 million for Q3 2025 and $10.4 million for Q2 2025.